Hoof on the till: Peters backs Optiscan med-tech
Bob Peters is used to backing winners – in fact he has bred and owned a great many of them on his way to becoming the king of WA horse...
top of page
Search
Doug Bright
Oct 26, 2023
Memphasys to reinvest tax refund in the next generation
Australian-based reproductive biotechnology company, Memphasys says it has received a research and development (R&D) tax refund of about...
Doug Bright
Sep 15, 2023
Memphasys brings Indian baby dreams alive with Felix
Just when all looked lost for a group of parent hopefuls in India, a groundbreaking piece of Australian medical technology developed by...
Michael Philipps
Aug 14, 2023
Memphasys franks Japan deal with first Felix order
Just a week into its pivotal deal with global IVF provider Vitrolife, reproductive biotechnology company Memphasys has already received...
Helen Barling
Aug 7, 2023
Memphasys inks deal with global IVF provider Vitrolife
Sydney-based reproductive technology specialist Memphasys has inked an exclusive five-year distribution deal with Vitrolife Japan KK – a...
Michael Philipps
Jul 13, 2023
Memphasys locks in new patents for flagship IVF treatment
Memphasys locks in new patents for flagship IVF treatment
Matt Birney
Jun 6, 2023
Memphasys goes to top of global sperm separation class
Reproductive biotechnology company Memphasys has received a boost for its flagship Felix system, with the first global study of its kind...
Matt Birney
Apr 11, 2023
ASX: MEM - Memphasys
It’s a boy! A remarkable feat for a biotech – a living breathing baby is born
bottom of page